Presentation is loading. Please wait.

Presentation is loading. Please wait.

RHEUMATIC HEART DISEASE

Similar presentations


Presentation on theme: "RHEUMATIC HEART DISEASE"— Presentation transcript:

1 RHEUMATIC HEART DISEASE
Dr Ubaid N P Community Medicine Pariyaram Medical College

2 Introduction Rheumatic fever –febrile disease affecting connective tissues, esp. heart and joints Sequele to throat infection by group A beta haemolytic streptococci RF is not a communicable disease – results from a communicable disease RF often leads to Rheumatic Heart Disease (RHD)

3 Problem statement 15 million cases of RHD worldwide
deaths due to RHD in 2008 Major cause of mitral insufficiency and stenosis In India prevalence more common on 5 – 15 age group (5-7/ thousand children) RF is said to occur in 1-3% of all streptococcal infections in children

4 Severity of valve disease is directly related to:
- no of previous attacks of RF - Length of time between onset of disease & start of therapy - Sex (F > M)

5 Agent Group A beta Haemolytic Streptococcus
Onset of RF is preceded by a streptococcal sore throat High carrier rate – convalescent, transcient and chronic carriers

6 Host & Environment Factors
Typically a childhood and adolescent disease (5 – 15 years) High incidence of ‘Juvenile mitral stenosis in India’ Prevalence in M = F, but prognosis is more worse in Female Disease is related to low standard of living High risk groups – school age children, slum dwellers, those living in closed community (e.g: barracks)

7 Clinical features Fever – acute, may last 12 weeks or longer, recurs
Polyarthritis – occurs in 90% cases, Large joints affected more commonly Carditis – valves and all layers involved, manifested by tachycardia, murmers, enlargement, pericarditis, heart failure, first degree AV block in ECG Nodules – small, painless nodules below skin Brain involvement – abnormal jerky movements of arms, legs and the body Skin involvement - various skin rashes

8

9

10 Diagnosis

11 Diagnosis

12 Prevention Primary prevention Secondary prevention:
- one i/m injection of benzathine pencillin (1.2 million in adults & 600,000 units in children) - given at an interval of 3 weeks, for at least 5 years or till the age of 18 years(which ever later) - severe valvular disease and post valve surgery cases need life long treatment Non medical measures

13


Download ppt "RHEUMATIC HEART DISEASE"

Similar presentations


Ads by Google